Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conversion from MMF to EC-MPS in Renal Transplant
NCT00171379Phase 3Completed
- Sponsor
- Novartis
- Start
- Mar 2004
- Primary completion
- Jun 2005
- Modality
- Small Molecules
01
Overview
Phase 3, open-label, single-arm trial of mycophenolate sodium in kidney transplant rejection, sponsored by Novartis. Primary endpoint: Renal function, measured as calculated creatinine clearance according to the Cockcroft and Gault formula. Started Mar 2004; status: completed.
02
Drugs
mycophenolate sodium
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00171379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00171379.